PFM
REGN icon

Parsec Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Parsec Financial Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$8.16M Buy
9,928
+21
+0.2% +$15.8K 0.34% 70
2022
Q4 		$7.15M Buy
9,907
+415
+4% +$306K 0.32% 73
2022
Q3 		$6.54M Buy
9,492
+383
+4% +$241K 0.33% 69
2022
Q2 		$5.38M Buy
9,109
+375
+4% +$244K 0.26% 75
2022
Q1 		$6.1M Buy
8,734
+656
+8% +$415K 0.26% 73
2021
Q4 		$5.1M Buy
8,078
+254
+3% +$156K 0.21% 79
2021
Q3 		$4.82M Buy
7,824
+978
+14% +$607K 0.21% 80
2021
Q2 		$3.82M Buy
6,846
+522
+8% +$264K 0.18% 89
2021
Q1 		$2.99M Buy
6,324
+794
+14% +$387K 0.15% 102
2020
Q4 		$2.67M Buy
5,530
+29
+0.5% +$15.7K 0.14% 104
2020
Q3 		$3.08M Sell
5,501
-273
-5% -$166K 0.19% 89
2020
Q2 		$3.6M Sell
5,774
-542
-9% -$308K 0.23% 83
2020
Q1 		$3.08M Sell
6,316
-1,215
-16% -$501K 0.23% 88
2019
Q4 		$2.83M Sell
7,531
-3,545
-32% -$1.19M 0.17% 101
2019
Q3 		$3.07M Sell
11,076
-4,518
-29% -$1.34M 0.19% 97
2019
Q2 		$4.88M Buy
15,594
+7,375
+90% +$2.46M 0.3% 80
2019
Q1 		$3.38M Buy
8,219
+5,830
+244% +$2.4M 0.21% 96
2018
Q4 		$892K Buy
+2,389
New +$874K 0.06% 144

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Parsec Financial Management's REGN Position: Q1 2023 in Review

Parsec Financial Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.21% in Q1 2023, buying an estimated $15.8K and bringing the position to 9,928 shares worth $8.16M. The position accounts for 0.34% of the portfolio, ranked #70.

Parsec Financial Management first reported a position in REGN in Q4 2018 and has held it in 18 quarters since. 1,192 funds tracked by Wall St. Rank hold REGN as of Q1 2023.

  • Parsec Financial Management held 9,928 shares of Regeneron Pharmaceuticals worth $8.16M as of Q1 2023.
  • Parsec Financial Management bought 21 Regeneron Pharmaceuticals shares in Q1 2023, an estimated $15.8K.
  • Regeneron Pharmaceuticals made up 0.34% of Parsec Financial Management's portfolio in Q1 2023, its #70 holding.
  • Parsec Financial Management first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • 1,192 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2023.

Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.